Lapatinib as a Chemotherapeutic Drug

E-ISSN： 2212-3970|4|3|216-226

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.4, Iss.3, 2009-11, pp. : 216-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study evaluating lapatinib in combination with nab -paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

By Yardley Denise

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 457-464

Springer Publishing Company

Access to resources Recommend Favorite

Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 669-676

Spandidos Publications

Access to resources Recommend Favorite

Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 185-192

Spandidos Publications

Access to resources Recommend Favorite

ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma

By Jin Yao Bin Zhang Qiang Huang Liang Chu Hua Chen Jun Dong Dong Wang Qing Lan

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1369-1376

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC) ?

Current Cancer Therapy Reviews, Vol. 12, Iss. 1, 2016-10 ,pp. : 54-65

Bentham Science Publishers

Access to resources Recommend Favorite